Table 3. GDS-independent dEQ biomarkers (unrelated to the GDS by Path c).
| Adiponectin (APN)![17] |
| Agouti-Related Protein (AgRP)![18] |
| alpha2-macroglobulin (α2M)‡[30, 49], ![18] |
| alpha-Fetoprotein (α-FP)![18] |
| Amphiregulin (AREG)![18] |
| angiopoetin-2N (ANG-2N)![17–18] |
| Angiotensin Converting Enzyme (ACE)![18] |
| Angiotensinogen![18] |
| apolipoprotein A1(APOA1)![18] |
| Apolipoprotein CIII (APOCIII)*[44–45], ![18] |
| AXL![18] |
| Betacellulin![18] |
| Bone Morphogenic Protein 6![18] |
| Brain-Derived Neurotrophic Factor (BDNF)*[44–45], ![18] |
| CD40![17–18] |
| Cancer Antigen 125 (CA 125)![18] |
| Cancer Antigen 19–9 (CA 19–9)![18] |
| Compliment 3 (C3)![17–18] |
| Connective Tissue Growth Factor (CTGF)![18] |
| Cortisol*[44–45], ![18] |
| C Reactive Protein (CRP)![18] |
| Creatinine Kinase-MB (CK-MB)![17–18] |
| Eotaxin-3![18] |
| Epidermal Growth Factor (EGF)*[44–45], ![18] |
| Epidermal Growth Factor Receptor 1 (EGFR)![17–18] |
| Epiregulin (EREG)![18] |
| Factor VII![18] |
| FAS-Ligand (FAS-L)![18] |
| Follicle stimulating hormone (FSH)![17–18] |
| Glutathione S-Transferase (GST)![17–18] |
| Granulocyte Colony Stimulating Factor (GCSF)![17–18] |
| Hepatocyte Growth Factor (HGF)![18] |
| Immunoglobulin A (IgA) |
| Immunoglobulin M (IgM)![17] |
| Insulin![17–18] |
| Insulin-like Growth Factor-Binding Protein 2 (IGF-BP2)![17–18] |
| Interferon-gamma‡[49], ![18] |
| Interleukin 1 receptor antagonist (IL-1ra)![18] |
| Interleukin 3 (IL-3)![18] |
| Interleukin 5 (IL-5)![17–18] |
| Interleukin 7 (IL-7)![18] |
| Interleukin 8 (IL-8)![17–18] |
| Interleukin 10 (IL-10)‡[49].! [18] |
| Interleukin 12-p40 (IL-12p40)‡[49], ![18] |
| Interleukin 13 (IL-13) ‡[30, 49], ![18] |
| Interleukin 15 (IL-15)†[50], ![18] |
| Interleukin 16 (IL-16)![18] |
| Lipoprotein a (LPA)![18] |
| Macrophage Inflammatory Protein type 1 beta (MIP-1b)![18] |
| Matrix Metalloproteinase type 3 (MMP-3)![18] |
| Monocyte Chemotactic Protein type 1 (MCP-1)![18] |
| Myoglobin (MyG)![17–18] |
| Pancreatic Polypeptide (PP)![17–18] |
| Plasminogen Activator Inhibitor type 1 (PAI-1)![17–18] |
| Platelet-Derived Growth Factor (PDGF)![17–18] |
| Progesterone![17–18] |
| Prolactin (PRL)†[63], *[44–45], ![18] |
| Prostate Specific Antigen (PSA)![18] |
| Pulmonary and Activation-Regulated Chemokine (PARC)![18] |
| Serum Amyloid P (SAP)![17–18] |
| Serum Glutamic Oxaloacetic Transaminase (SGOT)![18] |
| Soluable Advanced Glycosylation End Product-Specific Receptor) (sRAGE)![18] |
| Sortilin![18] |
| Stem Cell Factor (SCF)‡[49], ![18] |
| Tenascin C![17–18] |
| Testosterone![17–18] |
| Thrombopoietin (THPO)‡[30, 49], ![18] |
| Thrombospondin-1 (THBS1)![18] |
| Thyroxine Binding Globulin (TBG)![17–18] |
| Tissue Factor (TF)![18] |
| Tissue Growth Factor alpha (TGF-α)![18] |
| Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 3 (TRAIL-R3)![18] |
| Tumor Necrosis Factor alpha (TNF-α)‡[49], ![18] |
| Vitamin D Binding Protein (VDBP)†[51],![18] |
| Vascular Endothelial Growth Factor (VEGF)![18] |
| von Willebrand Factor (vWF)‡[30, 49], ![17–18] |
* Previously recognized depression-specific serum protein biomarker
‡Previously recognized δ biomarkers in Non-Hispanic White TARCC participants only
†Previously recognized ethnicity adjusted δ biomarkers
!Previously recognized GDS adjusted biomarkers